Factors Associated With Complete Remission After Rituximab Therapy for Pemphigus

Rituximab has emerged as a front-line therapy for pemphigus, but prognostic factors for achieving complete remission off therapy (CROT) with oral systemic agents remain unknown.To describe rates of CROT and relapse and identify prognostic factors for achieving CROT after rituximab therapy for pemphigus.A single-center, retrospective, cohort study was conducted at the University of Pennsylvania including 112 patients with pemphigus treated with...